 | • レポートコード：GIR-107A12497 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、無針ドラッグデリバリーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。無針ドラッグデリバリーの種類別市場規模（ジェット、スプリング、レーザー）、用途別市場規模（インスリン投与、予防接種、疼痛管理）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・無針ドラッグデリバリーの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Antares Pharma、Pharmajet、Optinose、Valeritas、Crossject、Injex Pharma、3M Pharmaceuticals、Becton Dickinson (BD)、MedImmune、Mystic Pharmaceuticals、Zogenix ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ジェット、スプリング、レーザー ・用途別分析2016年-2026年：インスリン投与、予防接種、疼痛管理 ・無針ドラッグデリバリーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・無針ドラッグデリバリーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・無針ドラッグデリバリーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・無針ドラッグデリバリーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・無針ドラッグデリバリーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Needle-Free Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Needle-Free Drug Delivery size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Needle-Free Drug Delivery market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Needle-Free Drug Delivery market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Jet-based
Spring-based
Laser-based
Market segment by Application, can be divided into
Insulin delivery
Vaccination
Pain management
Market segment by players, this report covers
Antares Pharma
Pharmajet
Optinose
Valeritas
Crossject
Injex Pharma
3M Pharmaceuticals
Becton Dickinson (BD)
MedImmune
Mystic Pharmaceuticals
Zogenix
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Needle-Free Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Needle-Free Drug Delivery, with revenue, gross margin and global market share of Needle-Free Drug Delivery from 2019 to 2021.
Chapter 3, the Needle-Free Drug Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Needle-Free Drug Delivery market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Needle-Free Drug Delivery research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Needle-Free Drug Delivery
1.2 Classification of Needle-Free Drug Delivery by Type
1.2.1 Overview: Global Needle-Free Drug Delivery Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Needle-Free Drug Delivery Revenue Market Share by Type in 2020
1.2.3 Jet-based
1.2.4 Spring-based
1.2.5 Laser-based
1.3 Global Needle-Free Drug Delivery Market by Application
1.3.1 Overview: Global Needle-Free Drug Delivery Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Insulin delivery
1.3.3 Vaccination
1.3.4 Pain management
1.4 Global Needle-Free Drug Delivery Market Size & Forecast
1.5 Global Needle-Free Drug Delivery Market Size and Forecast by Region
1.5.1 Global Needle-Free Drug Delivery Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Needle-Free Drug Delivery Market Size by Region, (2016-2021)
1.5.3 North America Needle-Free Drug Delivery Market Size and Prospect (2016-2026)
1.5.4 Europe Needle-Free Drug Delivery Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Needle-Free Drug Delivery Market Size and Prospect (2016-2026)
1.5.6 South America Needle-Free Drug Delivery Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Needle-Free Drug Delivery Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Needle-Free Drug Delivery Market Drivers
1.6.2 Needle-Free Drug Delivery Market Restraints
1.6.3 Needle-Free Drug Delivery Trends Analysis
2 Company Profiles
2.1 Antares Pharma
2.1.1 Antares Pharma Details
2.1.2 Antares Pharma Major Business
2.1.3 Antares Pharma Needle-Free Drug Delivery Product and Solutions
2.1.4 Antares Pharma Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Antares Pharma Recent Developments and Future Plans
2.2 Pharmajet
2.2.1 Pharmajet Details
2.2.2 Pharmajet Major Business
2.2.3 Pharmajet Needle-Free Drug Delivery Product and Solutions
2.2.4 Pharmajet Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pharmajet Recent Developments and Future Plans
2.3 Optinose
2.3.1 Optinose Details
2.3.2 Optinose Major Business
2.3.3 Optinose Needle-Free Drug Delivery Product and Solutions
2.3.4 Optinose Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Optinose Recent Developments and Future Plans
2.4 Valeritas
2.4.1 Valeritas Details
2.4.2 Valeritas Major Business
2.4.3 Valeritas Needle-Free Drug Delivery Product and Solutions
2.4.4 Valeritas Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Valeritas Recent Developments and Future Plans
2.5 Crossject
2.5.1 Crossject Details
2.5.2 Crossject Major Business
2.5.3 Crossject Needle-Free Drug Delivery Product and Solutions
2.5.4 Crossject Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Crossject Recent Developments and Future Plans
2.6 Injex Pharma
2.6.1 Injex Pharma Details
2.6.2 Injex Pharma Major Business
2.6.3 Injex Pharma Needle-Free Drug Delivery Product and Solutions
2.6.4 Injex Pharma Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Injex Pharma Recent Developments and Future Plans
2.7 3M Pharmaceuticals
2.7.1 3M Pharmaceuticals Details
2.7.2 3M Pharmaceuticals Major Business
2.7.3 3M Pharmaceuticals Needle-Free Drug Delivery Product and Solutions
2.7.4 3M Pharmaceuticals Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 3M Pharmaceuticals Recent Developments and Future Plans
2.8 Becton Dickinson (BD)
2.8.1 Becton Dickinson (BD) Details
2.8.2 Becton Dickinson (BD) Major Business
2.8.3 Becton Dickinson (BD) Needle-Free Drug Delivery Product and Solutions
2.8.4 Becton Dickinson (BD) Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Becton Dickinson (BD) Recent Developments and Future Plans
2.9 MedImmune
2.9.1 MedImmune Details
2.9.2 MedImmune Major Business
2.9.3 MedImmune Needle-Free Drug Delivery Product and Solutions
2.9.4 MedImmune Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 MedImmune Recent Developments and Future Plans
2.10 Mystic Pharmaceuticals
2.10.1 Mystic Pharmaceuticals Details
2.10.2 Mystic Pharmaceuticals Major Business
2.10.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Product and Solutions
2.10.4 Mystic Pharmaceuticals Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Mystic Pharmaceuticals Recent Developments and Future Plans
2.11 Zogenix
2.11.1 Zogenix Details
2.11.2 Zogenix Major Business
2.11.3 Zogenix Needle-Free Drug Delivery Product and Solutions
2.11.4 Zogenix Needle-Free Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Zogenix Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Needle-Free Drug Delivery Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Needle-Free Drug Delivery Players Market Share
3.2.2 Top 10 Needle-Free Drug Delivery Players Market Share
3.2.3 Market Competition Trend
3.3 Needle-Free Drug Delivery Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Needle-Free Drug Delivery Revenue and Market Share by Type (2016-2021)
4.2 Global Needle-Free Drug Delivery Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Needle-Free Drug Delivery Revenue Market Share by Application (2016-2021)
5.2 Needle-Free Drug Delivery Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Needle-Free Drug Delivery Revenue by Type (2016-2026)
6.2 North America Needle-Free Drug Delivery Revenue by Application (2016-2026)
6.3 North America Needle-Free Drug Delivery Market Size by Country
6.3.1 North America Needle-Free Drug Delivery Revenue by Country (2016-2026)
6.3.2 United States Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
6.3.3 Canada Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
6.3.4 Mexico Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Needle-Free Drug Delivery Revenue by Type (2016-2026)
7.2 Europe Needle-Free Drug Delivery Revenue by Application (2016-2026)
7.3 Europe Needle-Free Drug Delivery Market Size by Country
7.3.1 Europe Needle-Free Drug Delivery Revenue by Country (2016-2026)
7.3.2 Germany Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
7.3.3 France Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
7.3.5 Russia Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
7.3.6 Italy Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Needle-Free Drug Delivery Revenue by Type (2016-2026)
8.2 Asia-Pacific Needle-Free Drug Delivery Revenue by Application (2016-2026)
8.3 Asia-Pacific Needle-Free Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Needle-Free Drug Delivery Revenue by Region (2016-2026)
8.3.2 China Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
8.3.3 Japan Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
8.3.4 South Korea Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
8.3.5 India Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
8.3.7 Australia Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Needle-Free Drug Delivery Revenue by Type (2016-2026)
9.2 South America Needle-Free Drug Delivery Revenue by Application (2016-2026)
9.3 South America Needle-Free Drug Delivery Market Size by Country
9.3.1 South America Needle-Free Drug Delivery Revenue by Country (2016-2026)
9.3.2 Brazil Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
9.3.3 Argentina Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Needle-Free Drug Delivery Revenue by Type (2016-2026)
10.2 Middle East & Africa Needle-Free Drug Delivery Revenue by Application (2016-2026)
10.3 Middle East & Africa Needle-Free Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Needle-Free Drug Delivery Revenue by Country (2016-2026)
10.3.2 Turkey Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
10.3.4 UAE Needle-Free Drug Delivery Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Needle-Free Drug Delivery Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Needle-Free Drug Delivery Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Needle-Free Drug Delivery Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Needle-Free Drug Delivery Revenue (USD Million) by Region (2016-2021)
Table 5. Global Needle-Free Drug Delivery Revenue Market Share by Region (2021-2026)
Table 6. Antares Pharma Corporate Information, Head Office, and Major Competitors
Table 7. Antares Pharma Major Business
Table 8. Antares Pharma Needle-Free Drug Delivery Product and Solutions
Table 9. Antares Pharma Needle-Free Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pharmajet Corporate Information, Head Office, and Major Competitors
Table 11. Pharmajet Major Business
Table 12. Pharmajet Needle-Free Drug Delivery Product and Solutions
Table 13. Pharmajet Needle-Free Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Optinose Corporate Information, Head Office, and Major Competitors
Table 15. Optinose Major Business
Table 16. Optinose Needle-Free Drug Delivery Product and Solutions
Table 17. Optinose Needle-Free Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Valeritas Corporate Information, Head Office, and Major Competitors
Table 19. Valeritas Major Business
Table 20. Valeritas Needle-Free Drug Delivery Product and Solutions
Table 21. Valeritas Needle-Free Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Crossject Corporate Information, Head Office, and Major Competitors
Table 23. Crossject Major Business
Table 24. Crossject Needle-Free Drug Delivery Product and Solutions
Table 25. Crossject Needle-Free Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Injex Pharma Corporate Information, Head Office, and Major Competitors
Table 27. Injex Pharma Major Business
Table 28. Injex Pharma Needle-Free Drug Delivery Product and Solutions
Table 29. Injex Pharma Needle-Free Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. 3M Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. 3M Pharmaceuticals Major Business
Table 32. 3M Pharmaceuticals Needle-Free Drug Delivery Product and Solutions
Table 33. 3M Pharmaceuticals Needle-Free Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Becton Dickinson (BD) Corporate Information, Head Office, and Major Competitors
Table 35. Becton Dickinson (BD) Major Business
Table 36. Becton Dickinson (BD) Needle-Free Drug Delivery Product and Solutions
Table 37. Becton Dickinson (BD) Needle-Free Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. MedImmune Corporate Information, Head Office, and Major Competitors
Table 39. MedImmune Major Business
Table 40. MedImmune Needle-Free Drug Delivery Product and Solutions
Table 41. MedImmune Needle-Free Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Mystic Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 43. Mystic Pharmaceuticals Major Business
Table 44. Mystic Pharmaceuticals Needle-Free Drug Delivery Product and Solutions
Table 45. Mystic Pharmaceuticals Needle-Free Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Zogenix Corporate Information, Head Office, and Major Competitors
Table 47. Zogenix Major Business
Table 48. Zogenix Needle-Free Drug Delivery Product and Solutions
Table 49. Zogenix Needle-Free Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Needle-Free Drug Delivery Revenue (USD Million) by Players (2019-2021)
Table 51. Global Needle-Free Drug Delivery Revenue Share by Players (2019-2021)
Table 52. Breakdown of Needle-Free Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Needle-Free Drug Delivery Players Head Office, Products and Services Provided
Table 54. Needle-Free Drug Delivery Mergers & Acquisitions in the Past Five Years
Table 55. Needle-Free Drug Delivery New Entrants and Expansion Plans
Table 56. Global Needle-Free Drug Delivery Revenue (USD Million) by Type (2016-2021)
Table 57. Global Needle-Free Drug Delivery Revenue Share by Type (2016-2021)
Table 58. Global Needle-Free Drug Delivery Revenue Forecast by Type (2021-2026)
Table 59. Global Needle-Free Drug Delivery Revenue by Application (2016-2021)
Table 60. Global Needle-Free Drug Delivery Revenue Forecast by Application (2021-2026)
Table 61. North America Needle-Free Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Needle-Free Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Needle-Free Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Needle-Free Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Needle-Free Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Needle-Free Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Needle-Free Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Needle-Free Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Needle-Free Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Needle-Free Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Needle-Free Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Needle-Free Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Needle-Free Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Needle-Free Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Needle-Free Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Needle-Free Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Needle-Free Drug Delivery Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Needle-Free Drug Delivery Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Needle-Free Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Needle-Free Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Needle-Free Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Needle-Free Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Needle-Free Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Needle-Free Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Needle-Free Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Needle-Free Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Needle-Free Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Needle-Free Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Needle-Free Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Needle-Free Drug Delivery Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Needle-Free Drug Delivery Picture
Figure 2. Global Needle-Free Drug Delivery Revenue Market Share by Type in 2020
Figure 3. Jet-based
Figure 4. Spring-based
Figure 5. Laser-based
Figure 6. Needle-Free Drug Delivery Revenue Market Share by Application in 2020
Figure 7. Insulin delivery Picture
Figure 8. Vaccination Picture
Figure 9. Pain management Picture
Figure 10. Global Needle-Free Drug Delivery Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Needle-Free Drug Delivery Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Needle-Free Drug Delivery Revenue Market Share by Region (2016-2026)
Figure 13. Global Needle-Free Drug Delivery Revenue Market Share by Region in 2020
Figure 14. North America Needle-Free Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Needle-Free Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Needle-Free Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Needle-Free Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Needle-Free Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Needle-Free Drug Delivery Market Drivers
Figure 20. Needle-Free Drug Delivery Market Restraints
Figure 21. Needle-Free Drug Delivery Market Trends
Figure 22. Antares Pharma Recent Developments and Future Plans
Figure 23. Pharmajet Recent Developments and Future Plans
Figure 24. Optinose Recent Developments and Future Plans
Figure 25. Valeritas Recent Developments and Future Plans
Figure 26. Crossject Recent Developments and Future Plans
Figure 27. Injex Pharma Recent Developments and Future Plans
Figure 28. 3M Pharmaceuticals Recent Developments and Future Plans
Figure 29. Becton Dickinson (BD) Recent Developments and Future Plans
Figure 30. MedImmune Recent Developments and Future Plans
Figure 31. Mystic Pharmaceuticals Recent Developments and Future Plans
Figure 32. Zogenix Recent Developments and Future Plans
Figure 33. Global Needle-Free Drug Delivery Revenue Share by Players in 2020
Figure 34. Needle-Free Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Needle-Free Drug Delivery Revenue Market Share in 2020
Figure 36. Global Top 10 Players Needle-Free Drug Delivery Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Needle-Free Drug Delivery Revenue Share by Type in 2020
Figure 39. Global Needle-Free Drug Delivery Market Share Forecast by Type (2021-2026)
Figure 40. Global Needle-Free Drug Delivery Revenue Share by Application in 2020
Figure 41. Global Needle-Free Drug Delivery Market Share Forecast by Application (2021-2026)
Figure 42. North America Needle-Free Drug Delivery Sales Market Share by Type (2016-2026)
Figure 43. North America Needle-Free Drug Delivery Sales Market Share by Application (2016-2026)
Figure 44. North America Needle-Free Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 45. United States Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Needle-Free Drug Delivery Sales Market Share by Type (2016-2026)
Figure 49. Europe Needle-Free Drug Delivery Sales Market Share by Application (2016-2026)
Figure 50. Europe Needle-Free Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 51. Germany Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Needle-Free Drug Delivery Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Needle-Free Drug Delivery Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Needle-Free Drug Delivery Revenue Market Share by Region (2016-2026)
Figure 59. China Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Needle-Free Drug Delivery Sales Market Share by Type (2016-2026)
Figure 66. South America Needle-Free Drug Delivery Sales Market Share by Application (2016-2026)
Figure 67. South America Needle-Free Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Needle-Free Drug Delivery Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Needle-Free Drug Delivery Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Needle-Free Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Needle-Free Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の埋め込み型および無針ドラッグデリバリー市場予測（～2024年）：企業別、地域別、種類・用途別 Implantable drug delivery system becomes new kind of drug delivery system which can directly implant in the human body to optimize therapeutic properties. The needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic dis…- 無針ドラッグデリバリー装置市場：世界及び中国市場分析・予測（～2024年） Needle-Free Drug Delivery Devices Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Needle-Free Drug Delivery Devices industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ne…
- 無針ドラッグデリバリーシステム市場：世界及び中国市場分析・予測（～2024年） Needle-Free Drug Delivery Systems Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Needle-Free Drug Delivery Systems industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ne…
- 世界の無針ドラッグデリバリーデバイス市場予測（～2024年）：メーカー別、地域別、種類・用途別 The needle free drug delivery device uses mechanical devices to generate instantaneous pressure. Through the ion converter and the automatic drug delivery system, the liquid is pushed through a needle-free injection head to form a high-pressure body flow, which directly diffuses into the subcutaneou…
- 世界のジェット式無針注射器市場 2021：企業別、地域別、種類・用途別 The Jet-Based Needle-Free Injectors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…